By Daniel R. Matlis, President “Necessity is the mother of invention,” says the ancient proverb. In my opinion, the corollary is: “disruption is the matriarch …
Digital Transformation: The Business Imperative for Life Sciences Read More »
An open Letter to the Life-Sciences Industry on Analyst Forced Vendor Rankings By: Daniel R. Matlis As a Life-Science Industry Analyst, I am often asked …
Disruptions have eroded trust across Life-Science supply chains forcing brand owners to re-evaluate outsourcing programs in favor of Smart-Sourcing strategies that focus on quality, resilience, …
Digital Transformation Builds Trust Across the Value Network Read More »
By Daniel R. Matlis 15 years ago, Axendia was born of a need for trusted Life-Science advise and insights rooted in deep, firsthand industry experience …
Reduce Validation Efforts Up to 70% In this webinar presented jointly by Axendia, Bigfinite, and Honeywell, we will discuss how companies are increasing quality and …
Webinar: Real-Time Operations Intelligence for Life Sciences Read More »
A Straight from the Source Webinar To support changing regulatory frameworks and business models, forward thinking Life-Science companies like Fresenius Medical Care are not just …
Culture Change Management in Support of Digital Integration at Fresenius Medical Care Read More »
At Axendia, We Consider 13 More Than a Lucky Number! We are quickly approaching our 13 Year Anniversary! Since 2005, we have been providing trusted …
THEY SAY IT TAKES A VILLAGE TO RAISE A CHILD, WELL, IT TAKES A VILLAGE OF VOLUNTEERS TO WIN AN ERGO CUP® By: Mónica V. Matlis, Vice …
Managing the Chain of Custody and Identity for Regenerative Medicine Products. By: Daniel R. Matlis, President According to FDA Commissioner Scott Gottlieb, M.D. “We’re at the beginning of …
Lot Size: YOU – When YOU are the RAW MATERIAL and the FINISHED PRODUCT Read More »
An Interview with Francisco (Cisco) Vicenty – US FDA By: Daniel R. Matlis, President That is a question I often hear from industry executives around …
By: Giselle C. Matlis, Research Assistant On Monday June 26th 2017, Medtronic announced that they will be using a “new outcomes-based [payment] agreement with Aetna …
By: Ellyn McMullin, Research Associate and Daniel R. Matlis, President UDI Implementation – The Key to Unlock Personalized Medicine? The Senate has confirmed Cardiologist Robert …
New FDA Commissioner Adamant About Unique Device Identifiers (UDI) Read More »
